<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Pathophysiology on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/pathophysiology/</link><description>Recent content in Pathophysiology on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 21 May 2026 07:11:06 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/pathophysiology/index.xml" rel="self" type="application/rss+xml"/><item><title>Germinal-Centre and Extrafollicular B Cell Pathways in Systemic Lupus Erythematosus</title><link>https://rheumatologydigest.org/posts/gc-ef-b-cell-pathways-sle/</link><pubDate>Thu, 21 May 2026 07:11:06 +0530</pubDate><guid>https://rheumatologydigest.org/posts/gc-ef-b-cell-pathways-sle/</guid><description>This 2026 Nature Reviews Rheumatology paper reframes SLE autoantibody production by contrasting the germinal-centre and extrafollicular B cell pathways — their distinct kinetics, affinity profiles, T cell dependence, and therapeutic vulnerabilities — showing that the inflammatory niche, not intrinsic autoreactivity, determines pathogenic B cell fate.</description></item></channel></rss>